As molecular diagnostics and tumor profiling continue to advance our knowledge of cancer, so to
does our awareness of how inherently distinct influences like heredity, environment, and lifestyle affect
tumorgenesis and create a disease or tumor signature as distinct as that of a person’s handwriting.

Caris Dx is at the forefront of responding to the need for information to help tailor therapies and
improve patient outcomes by identifying biomarkers that oncologist’s can“target now”with
associated chemotherapeutic agents when standard therapies fail.